← Back to headlines
Wells Fargo Cuts Price Target on Soleno Therapeutics (SLNO)
Wells Fargo has reduced its price target for Soleno Therapeutics (SLNO) from $114 to $110, citing specific reasons for the adjustment.
1 Mar, 09:27 — 1 Mar, 09:27
Sources
Showing 1 of 1 sources
Related Stories
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
42m ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
4h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
4h ago
SEC Proposal Would Allow Companies to Announce Earnings Quarterly, Ditch Filings
5h ago